Cannae (NYSE:CNNE – Get Free Report) is expected to be issuing its Q2 2026 results after the market closes on Monday, August 10th. Analysts expect the company to announce earnings of ($0.4467) per share and revenue of $101.00 million for the quarter. Interested persons may visit the the company’s upcoming Q2 2026 earning overview page for the latest details on the call scheduled for Monday, August 10, 2026 at 5:00 PM ET.
Cannae (NYSE:CNNE – Get Free Report) last posted its quarterly earnings results on Monday, May 11th. The company reported ($0.70) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.40) by ($0.30). The company had revenue of $96.20 million during the quarter, compared to the consensus estimate of $99.77 million. Cannae had a negative net margin of 103.77% and a negative return on equity of 36.53%. The firm’s revenue for the quarter was down 6.8% compared to the same quarter last year. During the same quarter in the prior year, the business earned ($1.81) earnings per share. On average, analysts expect Cannae to post $-2 EPS for the current fiscal year and $-2 EPS for the next fiscal year.
Cannae Stock Up 2.6%
Shares of NYSE:CNNE traded up $0.38 during trading on Monday, hitting $14.93. 21,552 shares of the company were exchanged, compared to its average volume of 550,165. Cannae has a fifty-two week low of $10.46 and a fifty-two week high of $21.02. The stock has a market cap of $656.21 million, a price-to-earnings ratio of -1.90 and a beta of 1.20. The company has a current ratio of 1.71, a quick ratio of 1.71 and a debt-to-equity ratio of 0.07. The firm has a fifty day moving average price of $14.47 and a two-hundred day moving average price of $13.60.
Cannae Announces Dividend
Analyst Upgrades and Downgrades
A number of research analysts have recently commented on the stock. Stephens reissued an “overweight” rating and issued a $17.00 price objective on shares of Cannae in a research report on Thursday, April 23rd. Royal Bank Of Canada reiterated an “outperform” rating on shares of Cannae in a research note on Tuesday, May 12th. Finally, Weiss Ratings reiterated a “sell (d-)” rating on shares of Cannae in a report on Monday, July 6th. Two equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $17.00.
View Our Latest Stock Analysis on Cannae
Hedge Funds Weigh In On Cannae
Several institutional investors and hedge funds have recently modified their holdings of the stock. Raymond James Financial Inc. raised its position in shares of Cannae by 0.5% in the second quarter. Raymond James Financial Inc. now owns 267,358 shares of the company’s stock valued at $5,574,000 after purchasing an additional 1,265 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in shares of Cannae by 4.4% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 33,465 shares of the company’s stock worth $613,000 after buying an additional 1,405 shares during the last quarter. Invesco Ltd. boosted its holdings in shares of Cannae by 1.2% during the 3rd quarter. Invesco Ltd. now owns 180,882 shares of the company’s stock worth $3,312,000 after buying an additional 2,099 shares during the period. Envestnet Asset Management Inc. boosted its holdings in shares of Cannae by 27.4% during the 3rd quarter. Envestnet Asset Management Inc. now owns 12,614 shares of the company’s stock worth $231,000 after buying an additional 2,716 shares during the period. Finally, Quantbot Technologies LP acquired a new position in Cannae in the 2nd quarter valued at about $62,000. 88.12% of the stock is currently owned by institutional investors and hedge funds.
Cannae Company Profile
Cannae Holdings, Inc (NYSE: CNNE) is a publicly traded diversified holding company that focuses on partnering with and investing in businesses across a range of industry sectors. The company seeks to identify attractive opportunities in both private and public markets, leveraging its capital resources and management expertise to support operational growth and value creation. Cannae’s investment strategy emphasizes companies in data and analytics, marketing services, healthcare technology, and payment processing.
Through its portfolio, Cannae holds controlling or significant minority stakes in companies that provide critical software, data and services to corporate clients.
Recommended Stories
- Five stocks we like better than Cannae
- A Sweet Beat and a Wearables Rally Came With Reasons to Pause
- 3 Healthcare Stocks With Fresh Dividend Hikes and Different Income Profiles
- 3 Humanoid Robot ETFs to Ride a Speculative Trend
- Bearish Pressure Is Building Around These 3 Stocks
Receive News & Ratings for Cannae Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cannae and related companies with MarketBeat.com's FREE daily email newsletter.
